https://www.bioworld.com/articles/705958-teva-alvotech-land-approval-with-edge-in-humira-biosimilar-race
Teva, Alvotech land approval with edge in Humira biosimilar race | BioWorld
A preview of the next edition of BioWorld, Feb. 26, 2024
tevaalvotechlandapprovaledge
https://nordiclifescience.org/alvotech-completes-sek-750-million-private-placement/
Alvotech completes SEK 750 million private placement - NLS
Jun 5, 2025 - The transaction attracted interest from institutional investors, with a clear majority allocated to Swedish and other international investors outside of...
private placementalvotechcompletessekmillion
https://gabionline.net/pharma-news/New-Alvotech-partnerships-in-South-Africa-and-China
New Alvotech partnerships in South Africa and China
Iceland-based biopharmaceutical company Alvotech entered into two partnerships in November 2020, that will expand their reach into South Africa and...
south africanewalvotechpartnershipschina
https://markets.financialcontent.com/stocks/article/gnwcq-2025-5-9-alvotech-meets-investors-and-participates-in-fireside-chat-at-the-bofa-securities-healthcare-conference-2025-in-las-vegas-nevada
FinancialContent - Alvotech Meets Investors and Participates in Fireside Chat At the BofA...
Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada
fireside chatalvotechmeetsinvestorsparticipates
https://igmpi.ac.in/news/clinical-research/alvotech-declares-positive-findings-from-study-of-denosumab-biosimilar
Alvotech declares positive findings from study of denosumab biosimilar
Alvotech announces positive results for its Denosumab biosimilar study, advancing treatment options for osteoporosis and cancer-related bone issues.
alvotechdeclarespositivefindingsstudy
https://www.bigmoleculewatch.com/2021/01/05/global-drug-development-updates-alvotech-and-celltrion/
Global Drug Development Updates: Alvotech and Celltrion - Big Molecule Watch
Jan 13, 2021 - Last week, Alvotech closed out the year with an announcement that it is expanding its high-tech center in Reykjavik, Iceland. This high-tech center, which will...
drug developmentglobalupdatesalvotechbig
https://africasmbjournal.com/article/910894836-alvotech-q1-2026-financial-results
Alvotech Q1 2026 Financial Results | Africa SMB Journal
Africa SMB Journal is an online news publication focusing on sme/smb in the Africa: The best news from Africa on small business
financial resultsalvotechafricasmbjournal
https://www.webull.com/newslist/nasdaq-alvo
ALVO news, real time ALVO stock news, Alvotech news today - Webull
Webull offers ALVO stock news, real time Alvotech news help you invest smart.
real timealvonewsstocktoday
https://stocks-assistant.kreatebots.com/alvotech/2025/q2/summary
ALVOTECH 2025 Q2 - Summary | Stocks Assistant
Get detailed insights about ALVOTECH for Q2 of 2025.
alvotechsummarystocksassistant
https://mfn.se/one/a/alvotech/alvotech-q4-2025-and-full-year-2025-financial-results-9f8c115c
MFN.se Alvotech Alvotech Q4 2025 and Full Year 2025 Financial Results
Mar 18, 2026 - REYKJAVIK, Iceland, March 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental...
full yearfinancial resultsmfnsealvotech
https://synapse.patsnap.com/drug/dc3c992b9029409685f3c587fb621ca3
Aflibercept biosimilar (Alvotech) - Drug Targets, Indications, Patents - Synapse
drug targetsafliberceptbiosimilaralvotechindications
https://www.biopharmadive.com/news/alvotech-teva-biosimilars-expand-deal-funding/688726/
Teva strengthens ties with biosimilar maker Alvotech | BioPharma Dive
Despite setbacks with a Humira biosimilar, the partners have expanded an existing alliance, with Teva agreeing to purchase bonds while Alvotech pursues a stock...
biopharma divetevatiesbiosimilarmaker